What Are the Most Important Drug Interactions with Simvastatin?

Simvastatin carries multiple serious drug interactions that can significantly increase your risk of muscle injury and kidney damage. According to FDA drug labeling, at least nine classes or specific drugs are contraindicated (completely incompatible) with simvastatin, meaning the combination should not be used under any circumstances. Several others require strict dose limits or temporary suspension. The common underlying concern across nearly all simvastatin interactions is an increased risk of myopathy—muscle weakness and breakdown—and in severe cases, rhabdomyolysis, a potentially life-threatening muscle injury that can cause kidney failure. This guide explains the documented interactions, why they occur, and what you and your healthcare team should know to use simvastatin safely.

What Is Simvastatin?

Simvastatin is a statin—a class of medications that lower cholesterol by blocking an enzyme in the liver that produces cholesterol. It is widely prescribed to reduce the risk of heart disease and stroke in people with elevated cholesterol or other cardiovascular risk factors. Like all statins, simvastatin is processed (metabolized) by your liver, primarily through an enzyme system called cytochrome P450 3A4 (CYP3A4). This metabolic pathway is central to understanding simvastatin interactions: when another drug inhibits or competes with this enzyme, simvastatin can accumulate in your body to toxic levels.

Simvastatin is available in immediate-release tablets ranging from 5 mg to 80 mg. The dose your doctor prescribes depends on your cholesterol levels, kidney and liver function, and other medications you take. Understanding your current dose and which drugs interact with it is essential for safe use.

The Core Safety Issue: Myopathy and Rhabdomyolysis Risk

Nearly every simvastatin interaction documented in FDA labeling carries the same primary risk: myopathy and rhabdomyolysis. Myopathy is muscle disease or weakness; rhabdomyolysis is the breakdown of muscle tissue, which releases muscle proteins into the bloodstream. These proteins can damage the kidneys, potentially leading to acute kidney injury or kidney failure. Symptoms include unexplained muscle pain, tenderness, or weakness; dark or cola-colored urine; reduced urination; and fatigue. Any combination of simvastatin with a contraindicated drug can increase this risk substantially, even at standard simvastatin doses.

The FDA has documented these interactions through drug labeling analysis and post-market safety monitoring. The mechanism—in cases where it is known—typically involves reduced drug metabolism (the drug is not cleared from your body as quickly), causing simvastatin to reach higher-than-expected blood levels. However, the source records do not specify a detailed mechanism for most of these interactions. The key fact is that the combinations have been documented to increase myopathy risk based on clinical evidence and FDA regulatory review.

Drugs That Are Contraindicated (Do Not Use) with Simvastatin

The following drugs have an FDA contraindication with simvastatin, meaning the two should never be taken together under any circumstances:

Strong CYP3A4 Inhibitors

The single largest group of contraindicated drugs are strong CYP3A4 inhibitors. These are medications that powerfully block the liver enzyme that normally clears simvastatin from your body. When CYP3A4 is inhibited, simvastatin accumulates to dangerous levels. Drugs in this category include:

• Azole antifungals: itraconazole, ketoconazole, posaconazole, voriconazole (used to treat fungal infections)
• Macrolide antibiotics: erythromycin, clarithromycin, telithromycin (used to treat bacterial infections)
• HIV protease inhibitors: lopinavir/ritonavir, atazanavir, fosamprenavir calcium (used in HIV/AIDS treatment)
• Hepatitis C antivirals: boceprevir, telaprevir (used to treat hepatitis C)
• Other potent inhibitors: nefazodone (an antidepressant), and any product containing cobicistat (a booster used in HIV regimens)

According to FDA labeling, simvastatin is contraindicated with all of these agents. If you are taking any of these medications and your doctor has prescribed simvastatin, this is a critical safety issue to raise with your pharmacist or physician immediately. An alternative statin or a different antifungal, antibiotic, or HIV regimen may be necessary.

Gemfibrozil (Lopid)

Gemfibrozil is a fibrate—a different class of cholesterol and triglyceride-lowering drug. The FDA labeling for both simvastatin and gemfibrozil states that the two drugs are contraindicated together due to an increased risk of myopathy and rhabdomyolysis. The mechanism is not specified in the source record, but the evidence of risk is clear enough that the combination is prohibited.

Cyclosporine

Cyclosporine is an immunosuppressant drug used to prevent organ rejection after transplantation and to treat certain autoimmune conditions. The FDA labeling specifies that cyclosporine increases the risk of myopathy and rhabdomyolysis when used with simvastatin, and the combination is contraindicated. Patients on cyclosporine who need cholesterol management will require an alternative statin.

Danazol

Danazol is a synthetic hormone used to treat endometriosis and certain blood disorders. It is contraindicated with simvastatin due to increased myopathy risk.

Mifepristone (Korlym)

Mifepristone is a medication used to treat Cushing's syndrome (a disorder of excess cortisol production). FDA labeling notes that mifepristone significantly increases the exposure of simvastatin in the body, leading to contraindication due to myopathy and rhabdomyolysis risk.

Lonafarnib (Zokinvy)

Lonafarnib is a rare-disease medication used to treat progeria and similar conditions. FDA labeling states that coadministration with simvastatin is contraindicated due to serious drug interaction risk.

Drugs That Require Strict Dose Limits with Simvastatin

Several drugs are not absolutely contraindicated but require that your simvastatin dose be reduced significantly. Your doctor must monitor you closely and adjust your simvastatin dose downward if you need one of these medications.

Verapamil, Diltiazem, and Dronedarone

These are cardiac medications (calcium channel blockers and an antiarrhythmic, respectively). When used with simvastatin, the FDA recommends that simvastatin dose should not exceed 10 mg daily. If you are already on a higher dose of simvastatin and your doctor adds one of these drugs, your simvastatin dose will need to be reduced.

Amiodarone, Amlodipine, and Ranolazine

These are also cardiac medications. With these agents, simvastatin dose should not exceed 20 mg daily. Again, if you are on a higher dose, adjustment will be necessary.

Niacin (Vitamin B3) at High Doses

Niacin (nicotinic acid) is a B vitamin used to improve cholesterol and triglyceride levels. When niacin is used at doses of 1 gram per day or higher, the FDA recommends that it not be used with simvastatin in Chinese patients (this recommendation is population-specific as noted in the labeling). The reason for this population-specific guidance is not detailed in the source record, but the caution reflects data from that population showing increased myopathy risk.

Lomitapide

Lomitapide is a microsomal triglyceride transfer protein (MTTP) inhibitor used in homozygous familial hypercholesterolemia (HoFH), a rare genetic form of very high cholesterol. When used together, simvastatin dose should not exceed 20 mg daily in patients with HoFH. However, the FDA labeling notes an important exception: if you have been taking 80 mg simvastatin chronically (for 12 months or more) without evidence of muscle damage, your dose may be increased to no more than 40 mg daily when lomitapide is added. This exception reflects the judgment that chronic stable use at high dose without myopathy suggests lower individual risk.

Drugs Requiring Temporary Suspension or Avoidance

Daptomycin

Daptomycin is an antibiotic used to treat serious bacterial infections (particularly those caused by resistant organisms). If you need daptomycin, your doctor should temporarily suspend (stop) simvastatin during the course of daptomycin therapy. After daptomycin is finished, simvastatin may typically be restarted, but the timing and safety check should be confirmed with your physician.

Grapefruit Juice

While grapefruit juice is not a drug, it is a documented interaction because it contains compounds that inhibit CYP3A4—the same liver enzyme that metabolizes simvastatin. Consuming grapefruit juice can increase simvastatin levels in much the same way as a CYP3A4-inhibiting drug. The FDA recommends simply avoiding grapefruit juice entirely if you are taking simvastatin. This includes grapefruit juice in smoothies, supplements, or whole grapefruit fruit.

Ezetimibe and Simvastatin Combination Product

Simvastatin is also available as a fixed-dose combination tablet with ezetimibe (Vytorin), which enhances cholesterol lowering through a second mechanism. When simvastatin is part of an ezetimibe/simvastatin combination, all of the same drug interactions apply, and dose limits are adjusted for the combination product. For example, with verapamil or diltiazem, the combination should not exceed 10 mg/10 mg daily. With amiodarone, amlodipine, or ranolazine, it should not exceed 10 mg/20 mg daily. If you are taking this combination and your doctor is adding an interacting drug, work with your pharmacist to confirm the exact dose cap for the combination product.

Simvastatin and Coumarin Anticoagulants

FDA labeling for ezetimibe and simvastatin notes that simvastatin can prolong the INR (International Normalized Ratio) when used with coumarin anticoagulants such as warfarin. INR is a measure of how long it takes blood to clot; a prolonged INR increases bleeding risk. If you take warfarin or another coumarin and are prescribed simvastatin, your INR will need to be monitored, and your anticoagulant dose may need adjustment. This is not a contraindication but a documented interaction requiring medical supervision.

How These Interactions Work: General Pharmacology Background

To understand why these interactions occur, it helps to know how simvastatin moves through your body. After you take a simvastatin tablet, the drug is absorbed from your digestive tract and travels to the liver, where it is metabolized (chemically broken down) by the CYP3A4 enzyme into inactive forms that your body can eliminate. This process normally clears simvastatin from your bloodstream efficiently.

However, if another drug inhibits CYP3A4—meaning it blocks or slows down this enzyme—simvastatin is not cleared as quickly. It accumulates in your blood and tissues, reaching higher concentrations than intended. Simvastatin acts on muscle cells as part of its cholesterol-lowering action, and at high concentrations, it can cause muscle cell damage. Additionally, some of the contraindicated drugs (such as cyclosporine) may have their own muscle toxicity risks that are additive to simvastatin's risk.

Important note: The source records do not specify detailed mechanisms for all interactions. The above explanation of CYP3A4 inhibition is established general pharmacology relevant to many of these pairs, but it is presented as background context, not as proof of each individual interaction. The documented fact is that these drug combinations increase myopathy risk; the FDA has documented this through labeling review and safety monitoring.

Hypothetical Examples

Scenario 1: A patient with a fungal infection and high cholesterol. A 62-year-old man with elevated LDL cholesterol is prescribed simvastatin 40 mg daily. Six months later, he develops a stubborn toenail fungal infection and his dermatologist prescribes ketoconazole, an azole antifungal. Ketoconazole is a strong CYP3A4 inhibitor and is contraindicated with simvastatin. In this case, the patient and his healthcare team must choose: either switch to a different antifungal that does not interact with simvastatin, or temporarily stop simvastatin during the ketoconazole course and use a statin that does not rely on CYP3A4 metabolism (such as pravastatin). The dermatologist and cardiologist must communicate to make the safest choice.

Scenario 2: An elderly patient with heart rhythm problems and high cholesterol. A 75-year-old woman has been stable on simvastatin 20 mg daily for three years. Her cardiologist diagnoses atrial fibrillation and prescribes amiodarone to stabilize her heart rhythm. Amiodarone is documented to interact with simvastatin; the maximum safe dose of simvastatin when used with amiodarone is 20 mg daily. In this case, her current dose happens to be at the limit, so no adjustment is immediately needed—but her doctor will monitor her closely for muscle symptoms and repeat liver enzyme tests more frequently. If her doctor had prescribed simvastatin 40 mg or higher, the dose would have to be reduced to 20 mg or lower.

Summary of Contraindicated and Restricted Simvastatin Combinations

• Contraindicated (Do Not Use Together): Strong CYP3A4 inhibitors (itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, cobicistat-containing products), gemfibrozil, cyclosporine, danazol, mifepristone, lonafarnib
• Maximum 10 mg Simvastatin Daily: Verapamil, diltiazem, dronedarone
• Maximum 20 mg Simvastatin Daily: Amiodarone, amlodipine, ranolazine
• Maximum 20 mg Simvastatin Daily (Chinese Patients): Niacin ≥1 g/day
• Special Dosing for HoFH: Lomitapide (max 20 mg, or 40 mg if on stable high-dose simvastatin for ≥12 months)
• Temporarily Suspend Simvastatin: Daptomycin (restart after course completion, per physician approval)
• Avoid Completely: Grapefruit juice
• Monitor INR Closely: Coumarin anticoagulants (warfarin)

Questions to Ask Your Pharmacist or Physician

If you take simvastatin or are considering starting it, ask your healthcare team the following:

1. What is my current simvastatin dose, and why was that specific dose chosen for me?
2. Am I taking any strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol, or other contraindicated drugs? If so, should I switch to a different statin or the other medication?
3. If I am taking verapamil, diltiazem, amiodarone, amlodipine, or any other listed drug, has my simvastatin dose been set below the maximum allowed?
4. What are the early symptoms of muscle problems (myopathy) I should watch for, and when should I contact you if they occur?
5. Should I avoid grapefruit or grapefruit juice while taking simvastatin?
6. If a new medication is prescribed for me, will you check for interactions with my simvastatin before I fill the prescription?
7. How often will you monitor my liver enzymes and muscle-related blood work (creatine kinase, if indicated) while I am on simvastatin?
8. Are there any herbal supplements or over-the-counter products I should avoid while taking simvastatin?

Key Takeaways

• Simvastatin has at least nine classes of contraindicated drugs, primarily those that inhibit the CYP3A4 liver enzyme and those that independently increase myopathy risk. These combinations must be avoided entirely.
• Drugs such as verapamil, amiodarone, and amlodipine are not contraindicated but require strict dose limits on simvastatin (typically 10 or 20 mg daily maximum) to reduce myopathy and rhabdomyolysis risk.
• Myopathy (muscle weakness) and rhabdomyolysis (muscle breakdown) are the core safety concerns across nearly all simvastatin interactions. Symptoms include unexplained muscle pain, tenderness, weakness, and dark urine.
• Grapefruit juice is not a drug but a documented interaction that can increase simvastatin levels; it should be avoided entirely.
• Always inform your pharmacist and physician of all medications, supplements, and dietary habits before taking simvastatin, and ask about interactions whenever a new drug is added to your regimen.

Sources

The information in this article is sourced from FDA-approved drug labeling and the National Library of Medicine. Key authoritative sources include:

• DailyMed: FDA-Approved Drug Labeling Search — Access full FDA labeling for simvastatin, boceprevir, fosamprenavir calcium, gemfibrozil, lonafarnib, cobicistat, lopinavir/ritonavir, atazanavir, mifepristone, and ezetimibe/simvastatin combination products.
• Open FDA: Drug Interaction Database — Searchable repository of FDA-reviewed drug safety data and interaction warnings.
• RxNorm: National Library of Medicine Drug Terminology — Reference standard for drug names and identifiers used in clinical systems.
• PubMed: National Center for Biotechnology Information — Access to peer-reviewed clinical research on statin interactions and myopathy risk (optional search for specific studies).

Take the Next Step: Check Your Medications at checkdruginteractions.com

Simvastatin interactions are serious and can affect your health significantly. If you are currently taking simvastatin or any of the drugs mentioned in this guide, visit checkdruginteractions.com right now to enter your complete medication list and generate a personalized interaction report. The site will highlight any documented interactions between your drugs and explain what they mean for your safety. Then, schedule an appointment with your pharmacist or physician to review the results and confirm that your doses and drug combinations are safe. Never stop, start, or change a medication on your own; these decisions must be made in partnership with your healthcare team. Your safety depends on accurate, current information about all your medications working together.